1(31).indd

22 / 64

ОБЗОРЫ
22
РЕФЛЕКСОТЕРАПИЯ И КОМПЛЕМЕНТАРНАЯ МЕДИЦИНА
№ 1 (31) 2020
cutaneous electrostimulation device (MC5-A
Calmare®) for chemotherapy-induced pe-
ripheral neuropathy. J Pain Symptom Manage.
2010;40 (6):883-891. doi:10.1016/j.jpainsym-
man.2010.03.022.
9. Tonezzer T, Caffaro L A M, Menon K R S, et
al. Effects of transcutaneous electrical nerve
stimulation on chemotherapy-induced periph-
eral neuropathy symptoms (CIPN): a prelimi-
nary case-control study. J Phys Ther Sci. 2017;29
(4):685-692. doi:10.1589/jpts.29.685.
10. Kleckner I R, Kamen C, Gewandter J S, et al.
Effects of exercise during chemotherapy on
chemotherapy-induced peripheral neuropathy:
a multicenter, randomized controlled trial. Sup-
port Care Cancer. 2018;26 (4):1019-1028. doi:10
.1007/s00520-017-4013-0.
11. Streckmann F, Lehmann H C, Balke M, et al.
Sensorimotor training and whole-body vibration
training have the potential to reduce motor and
sensory symptoms of chemotherapy-induced
peripheral neuropathy-a randomized con-
trolled pilot trial. Support Care Cancer. 2019;27
(7):2471-2478. doi:10.1007/s00520-018-4531-4
12. Streckmann F, Hess V, Bloch W, et al. Indi-
vidually tailored whole-body vibration training
to reduce symptoms of chemotherapy-induced
peripheral neuropathy: study protocol of a ran-
domised controlled trial-VANISH. BMJ Open.
2019;9 (4):e024467. Published 2019 Apr 24.
doi:10.1136/bmjopen-2018-024467.
13. Geiger G, Mikus E, Dertinger H, Rick O. Low
frequency magnetic field therapy in patients with
cytostatic-induced polyneuropathy: a phase II
pilot study. Bioelectromagnetics. 2015; 36 (3):
251-4
14. Rick O, von Hehn U, Mikus E, Dertinger H,
Geiger G. Magnetic field therapy in patients with
cytostatics-induced polyneuropathy: A prospec-
tive randomized placebo-controlled phase-III
study. Bioelectromagnetics. 2017; 38 (2):85-94
15. Hanai A, Ishiguro H, Sozu T. et al. Effects of
Cryotherapy on Objective and Subjective Symp-
toms of Paclitaxel-Induced Neuropathy: Pro-
spectiveSelf-ControlledTrial. JNatlCancer Inst.
2018; 110 (2):141-148. doi:10.1093/jnci/djx178
16. Lee S Y, Kim J H, Han Y H, Cho D H. The ef-
fect of modulated electro-hyperthermia on tem-
perature and blood flow in human cervical carci-
noma. Int J Hyperthermia. 2018;34 (7):953-960.
doi:10.1080/02656736.2018.1423709.
17. Minnaar CA, Kotzen JA, Ayeni OA, et al. The
effect of modulated electro-hyperthermia on lo-
cal disease control in HIV-positive and -negative
cervical cancer women in South Africa: Early re-
sults from a phase III randomised controlled tri-
al. PLoS One. 2019;14 (6):e0217894. Published
2019 Jun 19. doi:10.1371/journal.pone.0217894.
18. Yang W, Han G H, Shin H Y, et al. Combined
treatment with modulated electro-hyperthermia
and an autophagy inhibitor effectively inhibit
ovarian and cervical cancer growth. Int J Hyper-
thermia. 2019;36 (1):9-20. doi:10.1080/0265673
6.2018.1528390.
19. Nahin R. L., Straus S. E. Research into com-
plementary and alternative medicine: prob-
lems and potential. BMJ. 2001; 322: 161-164.
doi:10.1136/bmj.322.7279.161.
20. Zick S M, Czuhajewski C, Fouladbakhsh J M,
et al. Integrative Oncology Scholars Program:
A Model for Integrative Oncology Educa-
tion. J Altern Complement Med. 2018;24 (9-
10):1018-1022. doi:10.1089/acm.2018.0184.
21. Grant S J, Hunter J, Seely D, Balnea-
ves L G, Rossi E, Bao T. Integrative On-
cology: International Perspectives. Integr
Cancer Ther. 2019;18:1534735418823266.
doi:10.1177/1534735418823266.
22. Яцкевич К. В. Рак – не приговор, а са-
мый серьёзный повод измениться. https://
med.wikireading.ru/20493.
23. Gorski D. Integrative oncology: really the best
of both worlds? Nat Rev Cancer 14, 692-700
(2014).
24. Deng G., Cassileth B. Integrative oncology:
an overview. Am Soc Clin Oncol Educ Book
2014:233-42.
25. Харитонова В.И., Янева-Балабанска И. Ин-
теграция медицинских систем – желаемое
и действительное (российско-болгарские
параллели). Сибирские исторические ис-
следования. 2017. №4: 180-209. УДК 614.2
doi: 10.17223/2312461X/18/11.